JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2006, 55(1):12-17

Interconversion of Stereochemically Unstable Chiral Drugs: Utilization of Chromatographic Techniques for the Study of Enantiomerization Part II: Practical Applications

A. Fedurcová1, J. Lehotay1, J. Čižmárik2
1 Univerzita Komenského v Bratislave, Fakulta chemickej a potravinárskej technológie, Katedra analytickej chémie, SR
2 Univerzita Komenského v Bratislave, Farmaceutická fakulta, Katedra farmaceutickej chémie, SR

Enantiomerization is a first-order reaction; it means interconversion of one enantiomer into another (and vice versa). This phenomenon is a typical feature of some configurationally unstable chiral compounds and it complicates separation of racemic mixtures. For the study of enantiomerization, chromatographic separation techniques (GC, SFC, CE, MEKC, HPLC) and NMR can be used. Chromatographic methods suitable for investigation of enantiomerization include dynamic chromatography (if time scales of enantiomerization and separation are the same) and stopped-flow chromatography (time scales of both processes are different). The present paper surveys the research of enantiomerization from 1975, when papers describing enantiomerization in greater detail were published, to the present. Today, mathematical approaches and computer-assisted deconvolution procedures are commonly used for evaluation of enantiomerization - calculation of thermodynamic parameters (ΔGapp, ΔHapp, ΔSapp) and rate constants (k1app, k(-1)app). The aim of many publications was not only determination of the enantiomerization energy barrier, but the influence of the chiral stationary phase on enantiomerization was studied as well. In some cases, enantiomerization was used for preparative purposes - a pure enantiomer was obtained and thus complicated synthesis was excluded.

Keywords: enantiomerization; interconversion; configuration unstable drugs; kinetic rate constants; chromatographic methods

Received: May 13, 2005; Accepted: July 18, 2005; Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fedurcová A, Lehotay J, Čižmárik J. Interconversion of Stereochemically Unstable Chiral Drugs: Utilization of Chromatographic Techniques for the Study of Enantiomerization Part II: Practical Applications. Čes. slov. farm. 2006;55(1):12-17.
Download citation

References

  1. Eliel, E. L. et al.: Stereochemistry of organic compounds. New York, Wiley, 1994. Go to original source...
  2. Jacobson, J., Melander, W., Vaisnys, G., Horváth, C.: J. Phys. Chem., 1984; 88, 4536. Go to original source...
  3. Rathore, A. S., Horváth, C.: Electrophoresis, 1997; 18, 2935. Go to original source... Go to PubMed...
  4. Bürkle, K., Karfunkel, H., Schurig, V.: J. Chromatogr., 1984; 288, 1-14. Go to original source...
  5. Trapp, O., Schurig, V.: J. High Resolution Chromatogr., 2000; 23, 291.
  6. Trapp, O., Schurig, V.: Computers and chemistry, 2001; 25, 187-195. Go to original source... Go to PubMed...
  7. Trapp, O., Schoetz, G., Schurig, V.: Chirality, 2001; 13, 403-414. Go to original source... Go to PubMed...
  8. Schurig, V., Reich, S.: Chirality, 1998; 10, 425-429. Go to original source...
  9. Reich, S., Schurig, V.: J. Microcol. Sep., 1999; 11, 475-479. Go to original source...
  10. Reich, S., Schurig, V.: GIT Lab. J, 1999; 3, 39.
  11. Reich, S., Trapp, O., Schurig, V.: J. Chromatogr. A, 2000; 892, 487-497. Go to original source... Go to PubMed...
  12. Reich, S., Schurig, V.: Proceedings of the 20th International Symposium on capillary chromatography, I. O. P. M. S. vzw., Kortrijk, Belgium, 1998; J.13.
  13. Wolf, Ch., Koenig, W. A., Roussel, C.: Chirality, 2004; 7, 610-611. Go to original source...
  14. Stephan, B., Zinner, H., Kastner, F., Mannschreck, A.: Chimia, 1990; 10, 336-338. Go to original source...
  15. Venciana, J., Crespo, M. I.: Angew. Chem. Int. Ed., 1991; 30, 74-77. Go to original source...
  16. Venciana, J., Crespo, M. I.: Angew. Chem., 1991; 103, 85. Go to original source...
  17. Kramer, R.: J. Chromatogr., 1975; 107, 241. Go to original source...
  18. Cremer, E., Kramer, R.: J. Chromatogr., 1975; 107, 253. Go to original source...
  19. Schurig, V., Trapp O.: J. Chromatogr. A, 2001; 911, 167-175. Go to original source... Go to PubMed...
  20. Trapp, O., Schurig, V.: J. Am. Chem. Soc., 2000; 122, 1424-1430. Go to original source...
  21. Kostyanovsky, R.G., Kadorkina, G. K., Kostyanovsky, V. R. et al.: Angew. Chem. Int. Ed. Engl., 2000; 39, 2938. Go to original source...
  22. Schurig, V., Bürkle, W.: J. Am. Chem. Soc., 1982; 104, 7573-7580. Go to original source...
  23. Weseloh, O., Wolf, C., König, W. A.: Angew. Chem. Int. Ed., 1995; 34, 1635-1636. Go to original source...
  24. Weseloh, O., Wolf, C., König, W. A.: Chirality, 1996; 8, 441-445. Go to original source...
  25. Marriot, P. J., Lai, Y-H.: J. Chromatogr., 1988; 447, 29-41. Go to original source...
  26. Marriot, P. J., Lai, Y-H.: Chem. Aust., 1994; 386-389.
  27. Jung, M.: Program SIMUL, No. 620. Quantum Chemistry program exchamnge. QCPE Bull 1992;3,12.
  28. Roth, A., Winzer, M., Korrel, M., Wildt, H.: Liebigs. Ann., 1995; 897-919. Go to original source...
  29. Schurig, V.: J. Chromatogr. A, 2002; 965, 315-356. Go to original source... Go to PubMed...
  30. Trapp, O.: Chirality, 2002; 14, 465-470. Go to original source... Go to PubMed...
  31. Reist, M., Christiansen, L. H., Christoffersen, P. et al.: Chirality, 1995; 7, 469-473. Go to original source...
  32. Hochmuth, D. H., König, W. A.: Liebigs. Ann., 1995; 947-951. Go to original source...
  33. Trapp, O., Schoetz, G., Schurig, V.: J. Pharm. Biomed. Anal., 2002; 27, 497-505. Go to original source... Go to PubMed...
  34. Schurig, V., Glausch, A., Fluck, M.: Tetrahedron Asymmetry, 1995; 6, 2161-2164. Go to original source...
  35. Fischer, Ch., Modler, A., Moinet, Ch., Fiaud, J.-C.: J. Chromatogr. A, 1996; 728, 433-439. Go to original source...
  36. Marriott, P.: J. Chromatogr. A, 2004; 1033, 135-143. Go to original source... Go to PubMed...
  37. Schurig, V., Reich, S.: Chirality, 1998; 10, 316-320. Go to original source...
  38. Schurig, V., Keller, F., Reich, S., Fluck, M.: Tetrahedron Assymmetry, 1997; 8, 3475-3480. Go to original source...
  39. Gasparrini, F., Lunayyi, L. Misiti, D., Villani, C.: Acc. Chem. Res., 1995; 28, 163-170. Go to original source...
  40. Melander, W. R., Lin, H.-J., Jacobson, J., Horváth, C.: J. Phys. Chem., 1984; 88, 4527-4536. Go to original source...
  41. Moriyasu, M., Kawanishi, K., Kato, A. et al.: Bull. Chem. Soc. Jpn., 1985; 58, 3351-3355. Go to original source...
  42. Moriyasu, M., Hashimoto, Z., Endo, M.: Bull. Chem. Soc. Jpn., 1983; 56, 1972-1977. Go to original source...
  43. Lebl, M., Gut, V.: J. Chromatogr., 1983; 260, 478-482. Go to original source...
  44. Böhmer, V., Caccamese, S., Principato, G., Schmidt, C.: Tetrahedron Letters, 1999; 40, 5927-5930. Go to original source...
  45. Cabrera, K., Jung, M., Fluck, M., Schurig, V.: J. Chromatogr. A, 1996; 731, 315-321. Go to original source...
  46. Cabrera, K., Lubda, D.: J. Chromatogr. A, 1994; 666, 433-438. Go to original source...
  47. Friaty, O., Spangler, M., Osterman, R. et al.: Chirality, 1996; 8, 364-371. Go to original source...
  48. Gasparrini, F., Misiti, D., Pierini, M., Villani, C.: Tetrahedron Assymmetry, 1997; 8, 2069-2073. Go to original source...
  49. Oxelbark, J., Allenmark, S.: J. Org. Chem., 1999; 64, 1483-1486. Go to original source... Go to PubMed...
  50. Thede, T., Haberland, D., Fischer, C.: J. Liquid Chromatogr. Rel. Technol., 1998; 21, 2089-2102. Go to original source...
  51. Gasparrini, F., Lunazzi, L., Mazzanti, A. et al.: J. Am. Chem. Soc., 2000; 122, 4776-4780. Go to original source...
  52. Torre la, F., Cirrili, R., Ferretti, R. et al.:: Chirality, 2003; 15, 429-432.
  53. Cirilli, R. Costi, R., Santo, Di R. et al.: J. Chromatogr. A, 2003; 993, 17-28. Go to original source... Go to PubMed...
  54. Trapp, O.: J. Biochem. Biophys. Meth., 2002; 54, 301-313. Go to original source... Go to PubMed...
  55. Kiesswetter, R., Brandl, F., Kastner-Pustet, N., Mannschreck, A.: Chirality, 2003; 15, S40-S49.
  56. Irurre, J., Santamaría, J., González-Rego, M. C.: Chirality, 1995; 7, 154-157. Go to original source...
  57. Abatangelo, A., Zanetti, F., Navarini, L. et al.: Chirality, 2002; 14, 12-17. Go to original source... Go to PubMed...
  58. Trapp, O.: Tetrahedron Assymmetry, 2001; 12, 1395-1398. Go to original source...
  59. Oswald, P., Desmet, K., Sandra, P. et al.: Chirality, 2002; 14, 334-339. Go to original source... Go to PubMed...
  60. Schoetz, G., Trapp, O., Schurig, V.: Enantiomer, 2000; 5, 391-396.
  61. Schoetz, G., Trapp, O., Schurig, V.: Anal. Chem., 2000; 2758-2764. Go to original source... Go to PubMed...
  62. Rathore, A. S., Horváth, C.: Electrophoresis, 1999; 20, 2691-2697. Go to original source...
  63. Scharwächter, K. P., Hochmuth, D. H., Dittmann, H., König, W. A.: Chirality, 2001; 13, 679-690. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.